Plasma phospho‐tau181 in over 400 cognitively healthy 69‐ to 71‐year‐olds: Associations with cerebral amyloid, structural imaging and cognition in the Insight 46 study: Biomarkers (non‐neuroimaging): Multimodal biomarker studies in cognitively unimpaired cohorts